These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22827853)

  • 21. [Crug formulation and liberation of the active ingredient in of chloroquine phosphate].
    Gyarmati L; Stampf G; Morzsányi E; Soós G; Nagy E; Ablonczy E
    Acta Pharm Hung; 1975 Jul; 45(4):155-9. PubMed ID: 1096532
    [No Abstract]   [Full Text] [Related]  

  • 22. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Wolfe F; Marmor MF
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):775-84. PubMed ID: 20535788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myopathy complicating lupus pregnancy.
    Priori R; Gattamelata A; d'Amati G; Giordano C; Piccioni MG; Valesini G; Framarino-dei-Malatesta M
    J Clin Rheumatol; 2013 Apr; 19(3):132-3. PubMed ID: 23519179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Eye toxicity of antimalarial agents].
    Graña Gil J; Cabana Vázquez M; Vázquez González A; Sánchez Meizoso MO
    An Med Interna; 2002 Apr; 19(4):189-91. PubMed ID: 12090061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corticosteroid-sparing strategies in the treatment of retinal vasculitis in systemic lupus erythematosus.
    Neumann R; Foster CS
    Retina; 1995; 15(3):201-12. PubMed ID: 7569347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.
    Jiménez-Alonso J; Tercedor J; Jáimez L; García-Lora E
    Arthritis Rheum; 1998 Apr; 41(4):744-5. PubMed ID: 9550488
    [No Abstract]   [Full Text] [Related]  

  • 27. [Complications in chloroquin therapy].
    Siegmeth W
    Acta Med Austriaca; 1975; 2(4):116-21. PubMed ID: 1241500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimalarial agents and lupus.
    Wallace DJ
    Rheum Dis Clin North Am; 1994 Feb; 20(1):243-63. PubMed ID: 8153401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type IV allergy to antimalarials can mimic cutaneous manifestations of lupus erythematosus.
    Borik L; Petzelbauer P; Quint T; Wöhrl S; Kinaciyan T; Heil PM
    J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):e94-e96. PubMed ID: 30223310
    [No Abstract]   [Full Text] [Related]  

  • 30. Reversible ageusia as an adverse effect of hydroxychloroquine treatment.
    Fleury O; Droitcourt C; Polard E; Chevrant-Breton J
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):604-5. PubMed ID: 18721220
    [No Abstract]   [Full Text] [Related]  

  • 31. Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival.
    Sisó A; Ramos-Casals M; Bové A; Brito-Zerón P; Soria N; Muñoz S; Testi A; Plaza J; Sentís J; Coca A
    Lupus; 2008 Apr; 17(4):281-8. PubMed ID: 18413408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Favorable effects of hydroxychloroquine on serum low density lipid in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
    Babary H; Liu X; Ayatollahi Y; Chen XP; Doo L; Uppaluru LK; Kwak MK; Kulaga C; Modjinou D; Olech E; Yoo JW
    Int J Rheum Dis; 2018 Jan; 21(1):84-92. PubMed ID: 28884965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimalarial drug retinopathy: A typical « Bull's eyes » appearance of fundus.
    Guiot A; Couturier M; Tebib JG; Abouaf L; Coury F
    Joint Bone Spine; 2018 May; 85(3):369. PubMed ID: 28512007
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunologic concepts of light reactions in lupus erythematosus and polymorphous light eruptions. I. The mechanism of action of hydroxychloroquine.
    Lester RS; Burnham TK; Fine G; Murray K
    Arch Dermatol; 1967 Jul; 96(1):1-10. PubMed ID: 5298279
    [No Abstract]   [Full Text] [Related]  

  • 35. Hydroxychloroquine-Induced Retinal Toxicity.
    Iselin KC; Marti P; Pless M
    Klin Monbl Augenheilkd; 2016 Apr; 233(4):514-6. PubMed ID: 27116524
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pleading to maintain hydroxychloroquine throughout Lupus pregnancies].
    Costedoat-Chalumeau N; Amoura Z; Le Thi Huong D; Wechsler B; Piette JC
    Rev Med Interne; 2005 Jun; 26(6):467-9. PubMed ID: 15936475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progression of hydroxychloroquine retinopathy after discontinuation of therapy: case report.
    Wei LC; Chen SN; Ho CL; Kuo YH; Ho JD
    Chang Gung Med J; 2001 May; 24(5):329-34. PubMed ID: 11480331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertrophic cardiomyopathy in a lupus patient: a case of hydroxychloroquine cardiotoxicity.
    Chang A; Stolin G; Fan J; Larreta BR; Fishbein GA; Wallace WD; Baas AS; Cruz D; Wang J
    ESC Heart Fail; 2019 Dec; 6(6):1326-1330. PubMed ID: 31493341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxychloroquine-induced cardiotoxicity in a 39-year-old woman with systemic lupus erythematosus and systolic dysfunction.
    Keating RJ; Bhatia S; Amin S; Williams A; Sinak LJ; Edwards WD
    J Am Soc Echocardiogr; 2005 Sep; 18(9):981. PubMed ID: 16153529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus.
    Gómez-Guzmán M; Jiménez R; Romero M; Sánchez M; Zarzuelo MJ; Gómez-Morales M; O'Valle F; López-Farré AJ; Algieri F; Gálvez J; Pérez-Vizcaino F; Sabio JM; Duarte J
    Hypertension; 2014 Aug; 64(2):330-7. PubMed ID: 24842914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.